Earnings Call · Q2 FY2025·2025-08-09

Q2 25EPS -58.33%·Rev n/aQ1 25EPS -11.10%·Rev n/aQ4 24EPS -26.09%·Rev n/aQ3 24EPS +12.29%·Rev n/a⚠ consensus missing

BridgeBio Pharma, Inc. BBIO

Chinmay Shukla — Senior Vice President of Strategic Finance

Neil Kumar — Chief Executive Officer

Matthew Outten — Chief Commercial Officer

Thomas Trimarchi — President

−8.9%1d on move date−9.7% vs SPY3d−5.3%5d−0.2%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BBIO calls or request research access.

More BBIO calls Browse calls Request research access